Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2019-08-28, Stock:PFE, The news for the past five days is as follows:
2019-08-21: NEWS1: Pfizer Digs Deeper Into Gene Therapy, Rivaling These Biotech Stocks.NEWS2: Record Stock Buybacks Fueled by Debt and Cash.NEWS3: Health Care Sector Update for 08/21/2019: NVTA,BIIB,ALT,PFE,ALC.NEWS4: Health Care Sector Update for 08/21/2019: NVTA,BIIB,ALT,PFE,ALC.NEWS5: Health Care Sector Update for 08/21/2019: ALT,PFE,ALC.NEWS6: Health Care Sector Update for 08/21/2019: ALT,PFE,ALC.NEWS7: Trade of the Day: Pfizer Stock Is Flashing Attractive Buy Signals.NEWS8: Trade of the Day: Pfizer Stock Is Flashing Attractive Buy Signals.NEWS9: U.S. FDA Grants XTANDI® (enzalutamide) Application Priority Review for the Treatment of Men with Metastatic Hormone-Sensitive Prostate Cancer.NEWS10: Gene Therapy Battle Heats Up: Will Pfizer Overwhelm Its Biotech Rivals?.NEWS11: Gene Therapy Battle Heats: Will Pfizer Overwhelm Its Biotech Rivals?.NEWS12: AstraZeneca's Imfinzi Fails in Stage IV Lung Cancer Study.NEWS13: AstraZeneca's Imfinzi Fails in Stage IV Lung Cancer Study.NEWS14: Teva Launches Generic Version of Mylan's EpiPen for KIds.NEWS15: Teva Launches Generic Version of Mylan's EpiPen for KIds.NEWS16: Pfizer invests $500 million in expanding gene therapy facility.NEWS17: Bayer Inks $7.6B Deal to Divest Animal Health Unit to Elanco.NEWS18: Bayer Inks $7.6B Deal to Divest Animal Health Unit to Elanco.NEWS19: Teva Launches Generic Version of Mylan's EpiPen for KIds.NEWS20: AstraZeneca's Imfinzi Fails in Stage IV Lung Cancer Study.NEWS21: Pfizer invests $500 million in expanding gene therapy facility.NEWS22: Pfizer to build $500M facility in Sanford, create hundreds of jobs.NEWS23: Pfizer to build $500 million facility in Sanford, create hundreds of jobs.NEWS24: Pfizer Invests Half Billion Dollars to Advance State-of-the-Art Gene Therapy Facility in Sanford, North Carolina.NEWS25: Health Care Sector Update for 08/21/2019: CERC, ALC, ALT, JNJ, PFE, ABT, MRK, AMGN.NEWS26: Health Care Sector Update for 08/21/2019: CERC, ALC, ALT, JNJ, PFE, ABT, MRK, AMGN.NEWS27: Trade of the Day: Pfizer Stock Is Flashing Attractive Buy Signals.NEWS28: Bayer Inks $7.6B Deal to Divest Animal Health Unit to Elanco.NEWS29: Bayer Sells Animal Health Division to Elanco: Now What?.NEWS30: Bayer Sells Animal Health Division to Elanco: Now What?.NEWS31: 3 Healthcare Stocks to Trade: UNH, JNJ and PFE.NEWS32: 3 Healthcare Stocks to Trade: UNH, JNJ and PFE.
2019-08-22: NEWS1: Pfizer's Xtandi Label Expansion Filing Gets Priority Review.NEWS2: Pfizer's Xtandi Label Expansion Filing Gets Priority Review.NEWS3: Health insurers will expand ACA coverage in 2020.NEWS4: Jim Cramer Weighs In On Pfizer, Teva And More.NEWS5: Pfizer's Xtandi Label Expansion Filing Gets Priority Review.NEWS6: Glaxo Submits First Regulatory Application for Daprodustat.NEWS7: 3 Dividend Stocks That Pay Better Than Coca-Cola.NEWS8: 3 Dividend Stocks That Pay Better Than Coca-Cola.NEWS9: 3 Dividend Stocks That Pay Better Than Coca-Cola.
2019-08-23: NEWS1: Dow Movers: CAT, BA.NEWS2: Dow Movers: CAT, BA.NEWS3: 'It's a little 'Star Trekky'': How this S.F. startup looks to create 3D-printed organs.NEWS4: Pharma Stock Roundup: ABBV's Rinvoq Gets FDA Nod, BAYRY to Sell Animal Health Unit.
2019-08-26: NEWS1: 52-Week Company Lows.
2019-08-27: NEWS1: US Indexes Close Lower Tuesday.NEWS2: Relative Strength Alert For Pfizer.NEWS3: Relative Strength Alert For Pfizer.NEWS4: 9 Hot Stocks to Buy Now.NEWS5: Notable ETF Outflow Detected - XLV, MRK, PFE, ABT.NEWS6: Notable ETF Outflow Detected - XLV, MRK, PFE, ABT.NEWS7: Only Eleven Dow Components With Recent Insider Buying, PFE is One of Them.NEWS8: Only Eleven Dow Components With Recent Insider Buying, PFE is One of Them.NEWS9: How Much Will It Cost Johnson & Johnson To Settle Most of Its Lawsuits?.NEWS10: How Much Will It Cost Johnson & Johnson To Settle Most of Its Lawsuits?.NEWS11: 4 Biotech Stocks to Buy That Are on the Move.NEWS12: Health Care Sector Update for 08/27/2019: NVTR, CTLT, JNJ, PFE, ABT, MRK, AMGN.NEWS13: Health Care Sector Update for 08/27/2019: NVTR, CTLT, JNJ, PFE, ABT, MRK, AMGN.NEWS14: 3 Cancer Treatment Stocks to Enrich Your Portfolio.NEWS15: Why Jim Cramer's Negative Take on Pfizer Is Flat-Out Wrong.NEWS16: Why Jim Cramer's Negative Take on Pfizer Is Flat-Out Wrong.NEWS17: Why Jim Cramer&apos;s Negative Take on Pfizer Is Flat-Out Wrong.

Answer: Rise